These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 9718866

  • 1. rHuEpo for the treatment of anemia in myelofibrosis with myeloid metaplasia. Experience in 6 patients and meta-analytical approach.
    Rodríguez JN, Martino ML, Diéguez JC, Prados D.
    Haematologica; 1998 Jul; 83(7):616-21. PubMed ID: 9718866
    [Abstract] [Full Text] [Related]

  • 2. Erythropoietin treatment of the anaemia of myelofibrosis with myeloid metaplasia: results in 20 patients and review of the literature.
    Cervantes F, Alvarez-Larrán A, Hernández-Boluda JC, Sureda A, Torrebadell M, Montserrat E.
    Br J Haematol; 2004 Nov; 127(4):399-403. PubMed ID: 15521916
    [Abstract] [Full Text] [Related]

  • 3. [Human recombinant erythropoietin in the treatment of myelodysplastic syndromes anemia. Meta-analytic study].
    Rodríguez JN, Diéguez JC, Muñiz R, Martino ML, Fernández-Jurado A, Amian A, Cañavate M, Prados D.
    Sangre (Barc); 1994 Dec; 39(6):435-9. PubMed ID: 7855695
    [Abstract] [Full Text] [Related]

  • 4. Danazol treatment of idiopathic myelofibrosis with severe anemia.
    Cervantes F, Hernández-Boluda JC, Alvarez A, Nadal E, Montserrat E.
    Haematologica; 2000 Jun; 85(6):595-9. PubMed ID: 10870115
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The evaluation of postdialysis L-carnitine administration and its effect on weekly requiring doses of rHuEPO in hemodialysis patients.
    Kadiroglu AK, Yilmaz ME, Sit D, Kara IH, Isikoglu B.
    Ren Fail; 2005 Jun; 27(4):367-72. PubMed ID: 16060121
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prediction of response to treatment with recombinant human erythropoietin in anaemia associated with cancer.
    Beguin Y.
    Med Oncol; 1998 Aug; 15 Suppl 1():S38-46. PubMed ID: 9785336
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. 2004 Japanese Society for Dialysis Therapy guidelines for renal anemia in chronic hemodialysis patients.
    Gejyo F, Saito A, Akizawa T, Akiba T, Sakai T, Suzuki M, Nishi S, Tsubakihara Y, Hirakata H, Bessho M, Japanese Society for Dialysis Therapy.
    Ther Apher Dial; 2004 Dec; 8(6):443-59. PubMed ID: 15663544
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Erythropoietin plus granulocyte colony-stimulating factor is better than erythropoietin alone to treat anemia in low-risk myelodysplastic syndromes: results from a randomized single-centre study.
    Balleari E, Rossi E, Clavio M, Congiu A, Gobbi M, Grosso M, Secondo V, Spriano M, Timitilli S, Ghio R.
    Ann Hematol; 2006 Mar; 85(3):174-80. PubMed ID: 16408206
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.